رجوع
9
18
نطاق اليوم
KWD 0.40
KWD 0.70
نطاق 52 أسبوعًا
KWD 0.40
KWD 0.70
حجم التداول
700
متوسط 50 يوم / 200 يوم
KWD 0.40
/
KWD 0.48
الإغلاق السابق
KWD 0.40
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 1.1 | 0.3 |
| P/B | 0.2 | 2.9 |
| ROE % | 15.0 | 3.7 |
| Net Margin % | 18.4 | 3.8 |
| Rev Growth 5Y % | 7.9 | 10.0 |
| D/E | 0.5 | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2027 |
KWD 0.288
KWD 0.261 – KWD 0.329
|
5.1 B | 1 |
| FY2026 |
KWD 0.219
KWD 0.198 – KWD 0.249
|
4.8 B | 1 |
النقاط الرئيسية
Revenue grew 7.89% annually over 5 years — modest growth
Earnings declined -19.53% over the past year
ROE of 15.00% — decent returns on equity
Net margin of 18.38% shows strong profitability
Debt/Equity of 0.50 — conservative balance sheet
Negative free cash flow of -49.39M
النمو
Revenue Growth (5Y)
7.89%
Revenue (1Y)-10.67%
Earnings (1Y)-19.53%
FCF Growth (3Y)N/A
الجودة
Return on Equity
15.00%
ROIC9.28%
Net Margin18.38%
Op. Margin23.27%
الأمان
Debt / Equity
0.50
Current Ratio2.78
Interest Coverage10.59
التقييم
P/E Ratio
1.12
P/B Ratio0.16
EV/EBITDA2.66
Dividend Yield0.03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -10.67% | Revenue Growth (3Y) | -5.27% |
| Earnings Growth (1Y) | -19.53% | Earnings Growth (3Y) | -2.79% |
| Revenue Growth (5Y) | 7.89% | Earnings Growth (5Y) | 14.75% |
| Profitability | |||
| Revenue (TTM) | 5.77B | Net Income (TTM) | 1.06B |
| ROE | 15.00% | ROA | 8.42% |
| Gross Margin | 50.37% | Operating Margin | 23.27% |
| Net Margin | 18.38% | Free Cash Flow (TTM) | -49.39M |
| ROIC | 9.28% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.50 | Current Ratio | 2.78 |
| Interest Coverage | 10.59 | Dividend Yield | 0.03% |
| Valuation | |||
| P/E Ratio | 1.12 | P/B Ratio | 0.16 |
| P/S Ratio | 0.21 | PEG Ratio | -0.83 |
| EV/EBITDA | 2.66 | Dividend Yield | 0.03% |
| Market Cap | 1.19B | Enterprise Value | 3.57B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 5.77B | 6.46B | 6.43B | 5.36B | 4.26B |
| Net Income | 1.06B | 1.32B | 1.12B | 785.53M | 611.97M |
| EPS (Diluted) | 0.36 | 0.44 | 0.38 | 0.26 | 0.20 |
| Gross Profit | 2.91B | 3.62B | 3.44B | 3.04B | 2.58B |
| Operating Income | 1.34B | 1.64B | 1.42B | 988.09M | 758.88M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 12.60B | 11.97B | 10.97B | 10.71B | 9.25B |
| Total Liabilities | 5.07B | 4.70B | 4.42B | 4.22B | 3.34B |
| Shareholders' Equity | 7.22B | 6.93B | 6.21B | 6.22B | 5.65B |
| Total Debt | 3.64B | 3.37B | 3.21B | 3.11B | 2.44B |
| Cash & Equivalents | 1.26B | 1.62B | 1.71B | 1.69B | 1.45B |
| Current Assets | 5.06B | 5.12B | 4.88B | 4.88B | 4.26B |
| Current Liabilities | 1.82B | 2.52B | 2.68B | 2.39B | 2.12B |
درجات الاستراتيجيات
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
#555 of 670
#499 of 709
النشاط الأخير
دخل
Contrarian Investing (David Dreman)
Mar 24, 2026
دخل
Defensive Investing (Benjamin Graham)
Mar 24, 2026